Hypertension is a
chronic medical condition in which the arterial blood pressure is elevated to
an undesired level. Also referred to as arterial hypertension or high blood
pressure in generic terms, the condition is measured in terms of systolic and
diastolic pressure. At rest blood pressure level is in the range of 120-140 mm
Hg systolic and 60-90mm Hg diastolic.
Hypertension arises when it is
persistently at or above the 140/90mm Hg level. Primary hypertension, a
condition with no underlying medical cause is highly prevalent than secondary
hypertension which is caused by other conditions such as kidney, heart,
endocrine or arterial disorders. Changing lifestyle habits such as diet,
smoking and exercising are the major cause of hypertension. Hypertension is one
of the most powerful risk factors for cardiovascular morbidity and mortality.
Browse
Full Report with TOC: http://www.transparencymarketresearch.com/anti-hypertensive-drugs.html
Based on their
therapeutic class, the anti-hypertensive drugs market is classified into
diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor
blockers (ARBs), calcium channel blockers, beta blockers, alpha blockers,
vasodilators and renin inhibitors. These drugs find their therapeutic use as
single drug administration or in fixed dose combinations. Diuretics are the
first line of treatment recommended by the physicians for most patients. However,
the drug preference depends on the patient’s medical history and current
conditions. For instance, a hypertensive patient with diabetes may be
recommended an ACE inhibitor as a first line treatment.
Hypertension is a
lifelong disease, which means that a patient may require to take medications
every day for the rest of his/her life. Thus, the demand for anti-hypertensive
dugs is sustainable and will increase with increase in the number of target
patients. Anti-hypertensive drugs were the second largest therapy area in 2011
with the global sales value of more than USD 40 billion, according to the World
Preview 2018 report by Evaluate Pharma.
This market however,
will be volatile due to patent expiries of blockbuster drugs, generic erosion,
and launch of novel molecules. For example, the patent expiration of
blockbuster drugs such as Diovan, Revatio, Avapro, Exforge and BIopress has
impacted the global anti-hypertensive market with the entry of generics. On the
other hand, the demand for fixed dose combinations is certain to rise, backed
by the increase in number of patients. Factors such as aging population and
lifestyle modifications will lead to an increase in the global incidence rate
of hypertension.
Some of the key players
contributing to the global anti-hypertensive drugs market include Novartis AG,
Pfizer, Inc., Johnson & Johnson Ltd., Sanofi S.A., Lupin Limited, Ranbaxy
Laboratories Limited, Merck & Co., Inc., Astra Zeneca Plc, Daiichi Sankyo
Company Limited and Takeda Pharmaceutical Company Limited.
This research report
analyzes this market depending on its market segments, major geographies, and
current market trends.
Geographies analyzed under this research report
include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides
comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming
years
This report is a
complete study of current trends in the market, industry growth drivers, and
restraints. It provides market projections for the coming years. It includes
analysis of recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players.
Reasons for Buying this
Report
- This report provides pin-point
analysis for changing competitive dynamics
- It provides a forward looking
perspective on different factors driving or restraining market
growth
- It provides a technological growth
map over time to understand the industry growth rate
- It provides a seven-year forecast
assessed on the basis of how the market is predicted to grow
- It helps in understanding the key
product segments and their future
- It provides pin point analysis of
changing competition dynamics and keeps you ahead of competitors
More Reports On Pharmaceutical Market: - http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
About Us:-
Transparency Market Research (TMR) is a
market intelligence company providing global business research reports and
consulting services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts,
researchers, and consultants use proprietary data sources along with various
tools and techniques to gather and analyze information. Our business offerings
represent the latest and the most reliable information which is indispensable
for businesses to sustain their competitive edge.
Our data repository is continuously
updated and revised by a team of research experts so that it always reflects
the latest trends and information. With broad research and analysis capability,
Transparency Market Research employs rigorous primary and secondary research
techniques in developing distinctive data sets and research material for
business reports.
Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Browse
Market Researche Report:-
0 comments:
Post a Comment